Comments
Auro Vaccines LLC, an arm of Aurobindo Pharma Ltd, has entered into a pact to acquire certain business assets from Profectus BioSciences Inc., US for an upfront cash consideration of $11.29 million (around ₹80 crore).
Auro Vaccines LLC is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, is a wholly-owned arm of the company, Hyderabad based Aurobindo Pharma said.
The indicative time period for completion of acquisition of research and development assets of Profectus BioSciences Inc is first half of 2020.
The acqusition provides access to proprietary and innovative technology platforms for prophylactic use and therapeutic use along with global R&D center, Aurobindo Pharma said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.